A Look Into Healthcare Sector Value Stocks
Portfolio Pulse from Benzinga Insights
The article discusses value stocks in the healthcare sector, highlighting five companies: Zymeworks, Cross Country Healthcare, Agile Therapeutics, Leafly Holdings, and Assertio Holdings. These companies have low price-to-earnings (P/E) multiples, indicating potential undervaluation. However, their Q2 earnings per share show mixed results, with some companies seeing increases and others decreases compared to Q1.
October 16, 2023 | 2:44 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Assertio Holdings has a low P/E multiple and saw a decrease in earnings per share from Q1 to Q2.
The low P/E multiple indicates potential undervaluation, but the decrease in earnings per share could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Cross Country Healthcare has a low P/E multiple and saw a decrease in earnings per share from Q1 to Q2.
The low P/E multiple indicates potential undervaluation, but the decrease in earnings per share could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Zymeworks has a low P/E multiple and saw a decrease in earnings per share from Q1 to Q2.
The low P/E multiple indicates potential undervaluation, but the decrease in earnings per share could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Agile Therapeutics has a low P/E multiple and saw an increase in earnings per share from Q1 to Q2.
The low P/E multiple indicates potential undervaluation, and the increase in earnings per share could positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Leafly Holdings has a low P/E multiple and saw an increase in earnings per share from Q1 to Q2.
The low P/E multiple indicates potential undervaluation, and the increase in earnings per share could positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100